AbbVie Inc. is 64.7x more valuable than Centessa Pharmaceuticals plc by market capitalization ($397.44 B vs $6.14 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CNTA | ABBV |
|---|---|---|
| Market cap | $6.14 B | $397.44 B |
| US-listed rank | #1252 | #28 |
| Revenue (latest FY) | $15.00M | $61.16B |
| Net income (latest FY) | -$197.53M | $4.23B |
| Net margin | -1316.9% | 6.9% |
| P/E (trailing FY) | - | 94.0 |
| SEC filings | 579 | 1,008 |
AbbVie Inc. is 64.7x more valuable than Centessa Pharmaceuticals plc by market capitalization ($397.44 B vs $6.14 B).
In their latest fiscal years, Centessa Pharmaceuticals plc reported $15.00M in revenue while AbbVie Inc. reported $61.16B.
Full pages: Centessa Pharmaceuticals plc and AbbVie Inc., or browse the full rankings.